• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Gradalis Highlights Importance of Clonal Neoantigens in Achieving Benefit in Cancer Treatment

    GLOBENEWSWIRE

    Gradalis Awarded $9.9 Million Grant From the Research Institute of Texas

    GLOBENEWSWIRE

    Gradalis to Host Virtual KOL Discussion on the Vigil® Platform Entering Phase 2

    GLOBENEWSWIRE

    Gradalis Highlights Importance of Clonal Neoantigen Targeting Benefit of Vigil

    GLOBENEWSWIRE

    Gradalis to Participate in the Cantor Global Healthcare Conference

    GLOBENEWSWIRE

    Gradalis Announces highlights Potential of Novel 3D Scaffold Tissue Technology

    GLOBENEWSWIRE

    Gradalis to Participate in the Cantor Fitzgerald Future of Oncology Symposium

    GLOBENEWSWIRE

    Gradalis Announces Publication in Clinical Cancer Research Featuring Positive Results from a Study Evaluating Vigil in Combination Therapy for Patients with Recurrent Ewing`s Sarcoma

    GLOBENEWSWIRE

    Gradalis to Present at the 2023 BIO CEO & Investor Conference

    GLOBENEWSWIRE

    US FDA grants approval for Gradalis’ Phase III ovarian cancer trial

    CLINICALTRIALSARENA

    Gradalis Receives Clearance to Begin Pivotal Phase 3 Clinical Trial of Vigil

    PRNEWSWIRE

    Gradalis Appoints Eric Hall as Chief Financial Officer

    GLOBENEWSWIRE

    Gradalis to Present at the 2022 Cell & Gene Meeting on the Mesa

    GLOBENEWSWIRE

    Gradalis to Host Key Opinion Leader Webinar on Unmet Medical in Ovarian Cancer

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.